Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A4ML
|
||||
Former ID |
DNC008841
|
||||
Drug Name |
4'-(2-butylbenzofuran-3-yl)biphenyl-4-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530028] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H22O2
|
||||
Canonical SMILES |
CCCCC1=C(C2=CC=CC=C2O1)C3=CC=C(C=C3)C4=CC=C(C=C4)O
|
||||
InChI |
1S/C24H22O2/c1-2-3-7-23-24(21-6-4-5-8-22(21)26-23)19-11-9-17(10-12-19)18-13-15-20(25)16-14-18/h4-6,8-16,25H,2-3,7H2,1H3
|
||||
InChIKey |
JIBMWJCMDPEYQP-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of Protein tyrosine phosphatase-1B | Target Info | Inhibitor | [530028] | |
KEGG Pathway | Adherens junction | ||||
Insulin signaling pathway | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Cadherin signaling pathway | ||||
Pathway Interaction Database | Insulin Pathway | ||||
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) | |||||
Signaling events mediated by PTP1B | |||||
Calcineurin-regulated NFAT-dependent transcription in lymphocytes | |||||
Signaling events mediated by TCPTP | |||||
IGF1 pathway | |||||
EGF receptor (ErbB1) signaling pathway | |||||
Posttranslational regulation of adherens junction stability and dissassembly | |||||
PDGFR-beta signaling pathway | |||||
N-cadherin signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.